Skip to content

Concomitant Tricuspid Repair in Patients With Left Heart Surgery

Concomitant Tricuspid Repair in Patients With Left Heart Surgery: Randomized Controlled Trial

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05595187
Enrollment
400
Registered
2022-10-26
Start date
2024-05-01
Completion date
2026-12-31
Last updated
2023-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiopulmonary Bypass, Mitral Regurgitation, Tricuspid Regurgitation

Brief summary

Tricuspid regurgitation is common in patients with severe left heart diseases, such as degenerative mitral regurgitation. However, the evidence base is insufficient to inform a decision about whether to perform concomitant tricuspid-valve repair during left heart surgery in patients who have mild tricuspid regurgitation. To inform decision making, we will conduct a multicenter, randomized trial to assess the benefits and risks of tricuspid-valve repair at the time of left heart diseases in patients with mild tricuspid regurgitation who were undergoing surgery for left heart surgery.

Interventions

DEVICETricuspid repair

Tricuspid repair included suture placement and the type of prosthetic annuloplasty.

Sponsors

Nanjing Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Patients undergoing left heart valve surgery with mild tricuspid regurgitation; 2. Patients aged 18-80 years; 3. Agree to participate in this study and sign the informed consent form.

Exclusion criteria

1. Infective endocarditis within 3 months; 2. Primary tricuspid regurgitation; 3. Isolated tricuspid regurgitation 4. Lactating women and suspected pregnant or pregnant women; 5. Patients with mental disorders, drug and alcohol dependence; 6. Those who participated in other clinical trials one month before the trial; 7. Refusal to participate in this study without informed consent.

Design outcomes

Primary

MeasureTime frameDescription
A composite of adverse cardiovascular events2 years after surgery at follow-upa composite of reoperation for tricuspid regurgitation, progression of tricuspid regurgitation from baseline by two grades or the presence of severe tricuspid regurgitation, or death.

Countries

China

Contacts

Primary ContactHong Liu, MD
dr.hongliu@foxmail.com18801281613
Backup ContactYong-feng Shao, MD
yfshaojph@sina.com02568303101

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026